Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CS-NEURO-1
- Development stage
- Unknown
- Lead developer
- Cannabis Science
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
CS-NEURO-1 is an investigational cannabis-based pharmaceutical product developed for the treatment of neurological conditions, including anxiety disorders and attention deficit hyperactivity disorder (ADHD). The drug is being developed by Cannabis Science, with formulation and preclinical work conducted in partnership with ImmunoClin. The active components are derived from specific cannabis strains, focusing on cannabinoids as the primary therapeutic agents. The mechanism of action likely involves modulation of the endocannabinoid system, which plays a role in regulating mood, anxiety, and neuroinflammation. As of early 2022, CS-NEURO-1 has reached Phase 1 clinical trials in the United States for anxiety disorders and ADHD[1][2].
Beyond the preview
Go deeper on CS-NEURO-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CS-NEURO-1.